Letter from Singapore: The clinical and research response to COVID-19.
作者信息
Chotirmall Sanjay H, Wang Lin-Fa, Abisheganaden John A
机构信息
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
出版信息
Respirology. 2020 Oct;25(10):1101-1102. doi: 10.1111/resp.13929. Epub 2020 Aug 17.
Abstract
摘要
相似文献
1
Letter from Singapore: The clinical and research response to COVID-19.来自新加坡的信：对新冠疫情的临床与研究应对措施
Respirology. 2020 Oct;25(10):1101-1102. doi: 10.1111/resp.13929. Epub 2020 Aug 17.
2
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore.应对 COVID-19 疫情挑战：来自新加坡放射肿瘤服务的观点。
Radiother Oncol. 2020 Jul;148:189-193. doi: 10.1016/j.radonc.2020.03.030. Epub 2020 Mar 31.
3
Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.2020 年 1 月 23 日至 3 月 16 日新加坡出现的 SARS-CoV-2 病前传播。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415. doi: 10.15585/mmwr.mm6914e1.
4
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
5
Reply to Guglielmo Mantica, Nazareno Suardi, and Carlo Terrone's Letter to the Editor re: Ming-Chun Chan, Sharon E.K. Yeo, Yew-Lam Chong, Yee-Mun Lee. Stepping Forward: Urologists' Efforts During the COVID-19 Outbreak in Singapore. Eur Urol 2020;78:e38?9.回复古列尔莫·曼蒂卡、纳扎雷诺·苏阿尔迪和卡洛·泰罗内致编辑的信，信的主题为：陈明春、杨雪恩、钟耀林、李义文。向前迈进：新加坡泌尿外科医生在2019年冠状病毒病疫情期间所做的努力。《欧洲泌尿外科杂志》2020年；78卷：e38 - e39。
Eur Urol. 2020 Oct;78(4):e167-e168. doi: 10.1016/j.eururo.2020.04.071. Epub 2020 May 8.
6
Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.新加坡 SARS-CoV-2 感染与 mRNA SARS-CoV-2 疫苗接种后颅内静脉血栓形成的发生率。
JAMA Netw Open. 2022 Mar 1;5(3):e222940. doi: 10.1001/jamanetworkopen.2022.2940.
7
Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.2020 年 4 月至 5 月，新加坡 4 例 COVID-19 合并结核病患者。
Emerg Infect Dis. 2020 Nov;26(11):2764-2766. doi: 10.3201/eid2611.202752. Epub 2020 Jul 15.
8
9
Singapore COVID-19 Pandemic Response as a Successful Model Framework for Low-Resource Health Care Settings in Africa?新加坡的 COVID-19 疫情应对能否成为非洲资源匮乏的医疗保健环境的成功模式框架？
OMICS. 2020 Aug;24(8):470-478. doi: 10.1089/omi.2020.0077. Epub 2020 Jun 16.
10
A Comparison of Case Fatality Risk of COVID-19 between Singapore and Japan.新加坡与日本新冠肺炎病例致死风险的比较
J Clin Med. 2020 Oct 16;9(10):3326. doi: 10.3390/jcm9103326.
引用本文的文献
1
A multi-institutional exploration of emergency medicine physicians' attitudes and behaviours on antibiotic use during the COVID-19 pandemic: a mixed-methods study.一项多机构探索性研究，旨在探讨 COVID-19 大流行期间急诊医师对抗生素使用的态度和行为：一项混合方法研究。
Antimicrob Resist Infect Control. 2023 Mar 29;12(1):24. doi: 10.1186/s13756-023-01230-2.
2
Reliability of COVID-19 symptom checkers as national triage tools: an international case comparison study.新冠症状筛查工具作为国家分诊工具的可靠性：一项国际病例比较研究。
BMJ Health Care Inform. 2021 Oct;28(1). doi: 10.1136/bmjhci-2021-100448.
3
One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.一年回顾：新加坡应对 COVID-19 的概述——我们做了什么、表现如何、如何继续前进。
Int J Environ Res Public Health. 2021 Aug 30;18(17):9125. doi: 10.3390/ijerph18179125.
4
We are not doing enough to prevent the spread of COVID-19 and other respiratory viruses in Australian hospitals.我们在预防新冠病毒和其他呼吸道病毒在澳大利亚医院传播方面做得还不够。
Med J Aust. 2021 Aug 16;215(4):152-153.e1. doi: 10.5694/mja2.51183. Epub 2021 Jul 21.
5
Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms.病毒相关性关节炎：COVID-19 感染的新表现？一项 COVID-19 相关肌肉骨骼症状的队列研究。
Int J Infect Dis. 2021 Mar;104:363-369. doi: 10.1016/j.ijid.2021.01.031. Epub 2021 Jan 18.
本文引用的文献
1
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.一种基于抗体介导的 ACE2-刺突蛋白-蛋白相互作用阻断的 SARS-CoV-2 假病毒中和试验。
Nat Biotechnol. 2020 Sep;38(9):1073-1078. doi: 10.1038/s41587-020-0631-z. Epub 2020 Jul 23.
2
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.COVID-19 和 SARS 病例以及未感染对照者的 SARS-CoV-2 特异性 T 细胞免疫。
Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15.
3
Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler.采用便携式 PCR 热循环仪进行无需 RNA 提取的 SARS-CoV-2 快速直接核酸扩增检测。
Genes (Basel). 2020 Jun 18;11(6):664. doi: 10.3390/genes11060664.
4
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients.检测感染患者病房空气中和表面的 SARS-CoV-2 污染情况。
Nat Commun. 2020 May 29;11(1):2800. doi: 10.1038/s41467-020-16670-2.
5
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.瑞德西韦治疗重症 COVID-19 患者的 5 天与 10 天疗程比较
N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27.
6
Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients.清醒俯卧位通气用于非插管氧依赖型 COVID-19 肺炎患者。
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.01198-2020. Print 2020 Jul.
7
Life at the Editorial "COVID Frontline". The American Thoracic Society Journal Family.编辑部门“新冠疫情前线”的工作生活。美国胸科学会期刊大家庭。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1457-1459. doi: 10.1164/rccm.202005-1516ED.
8
Connecting clusters of COVID-19: an epidemiological and serological investigation.连接 COVID-19 集群：一项流行病学和血清学调查。
Lancet Infect Dis. 2020 Jul;20(7):809-815. doi: 10.1016/S1473-3099(20)30273-5. Epub 2020 Apr 21.
9
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research.应对新冠疫情的挑战：给肺科与重症医学的建议及研究议程
Am J Respir Crit Care Med. 2020 May 1;201(9):1019-1022. doi: 10.1164/rccm.202003-0741ED.
10
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
Zotero 插件